Cardiovascular and Metabolic Disorders Archive

Injectable Progestin-Only Contraceptives May Increase Risk for VTE

Injectable Progestin-Only Contraceptives May Increase Risk for VTE

Investigators examined the effect of progestin-only contraceptive on cardiometabolic outcomes, including stroke, MI, hypertension, diabetes, and VTE.

Fewer Major Adverse Cardiovascular Events With New Antihyperglycemic Drugs With Lower Hypoglycemic Risk

Fewer Major Adverse Cardiovascular Events With New Antihyperglycemic Drugs With Lower Hypoglycemic Risk

Investigators proposed that reduction in MACE may be proportional to the magnitude of HbA1c reduction seen with newer antihyperglycemic agents.

Metabolic Syndrome Linked to Reduced Neurocognitive Function in Midlife

Metabolic Syndrome Linked to Reduced Neurocognitive Function in Midlife

Researchers found that metabolic syndrome was associated with lower neurocognitive function, particularly among middle-aged adults.

Osteoporosis Drug Shows Cardioprotective Potential at 10-Year Follow-Up

Osteoporosis Drug Shows Cardioprotective Potential at 10-Year Follow-Up

The 1-year cardiovascular mortality hazard ratio (HR) for alendronate users was 0.33 (95% CI, 0.17 to 0.65) and 0.55 for incident myocardial infarction (95% CI, 0.34 to 0.89).

Eplerenone May Improve Cardiovascular Disease Risk in HIV

Eplerenone May Improve Cardiovascular Disease Risk in HIV

Researchers investigated effects of eplerenone on insulin sensitivity, inflammatory indices, and other metabolic parameters in HIV.

Antipsychotics Increase Risk for Metabolic Syndrome, CVD in Younger Patients

Antipsychotics Increase Risk for Metabolic Syndrome, CVD in Younger Patients

Younger patients treated with antipsychotics after experiencing a first episode of psychosis are at an increased risk for metabolic syndrome and cardiovascular disease.

In LVSD, Diabetes Tied to Higher Risk of Heart Failure

In LVSD, Diabetes Tied to Higher Risk of Heart Failure

In patients with asymptomatic left ventricular systolic dysfunction, diabetes is associated with an increased risk of developing heart failure.

Metabolic Syndrome Frequency Assessed in Systemic Lupus Erythematosus

Metabolic Syndrome Frequency Assessed in Systemic Lupus Erythematosus

The frequency of metabolic syndrome among patients with SLE was approximately 45%.

Metabolic Syndrome Associated With Higher ALT Levels in Chronic Hepatitis B

Metabolic Syndrome Associated With Higher ALT Levels in Chronic Hepatitis B

Findings highlight the importance of screening for metabolic syndrome (MS) and the potential for MS to influence alanine aminotransferase and its interpretation in the context of HBV treatment decisions.

Increased Risk for Mortality in People With Diabetes, CHD Taking Beta-Blockers

Increased Risk for Mortality in People With Diabetes, CHD Taking Beta-Blockers

Further studies are needed to assess whether beta-blockers are effective in reducing mortality and coronary events in patients with diabetes receiving optimal medical treatment.

Sacubitril/Valsartan May Help Preserve Kidney Function in Patients With HFrEF

Sacubitril/Valsartan May Help Preserve Kidney Function in Patients With HFrEF

Compared with the enalapril-treated group, those treated with sacubitril/valsartan were found to have significantly slower kidney decline.

ADA Updates Guidelines for Cardiovascular Risk Management in Diabetes

ADA Updates Guidelines for Cardiovascular Risk Management in Diabetes

The American Diabetes Association has updated its Clinical Standards of Medical Care guidelines for identifying and managing cardiovascular risk factors in diabetes.

Menopause Symptom Severity May Predict Heart Disease

Menopause Symptom Severity May Predict Heart Disease

Researchers examined whether menopausal symptoms, quality of life, and depression are related to arterial stiffness, a risk factor for cardiovascular disease.

Eating Pecans May Cut Risk for Cardiovascular Disease, Diabetes

Eating Pecans May Cut Risk for Cardiovascular Disease, Diabetes

Changes in serum insulin and homeostatic model assessment of insulin resistance and beta cell function were significantly greater compared to the control diet

Noninvasive CAD Screening May Reduce Cardiac Events in Individuals With Asymptomatic Diabetes

Noninvasive CAD Screening May Reduce Cardiac Events in Individuals With Asymptomatic Diabetes

Compared with standard care, noninvasive coronary artery disease screening reduced cardiac events by 27% in individuals with asymptomatic diabetes. Results justify larger, appropriately powered trials to potentially revisit current recommendations.

Risk for Cardiovascular Disease Higher in Survivors of Testicular Cancer

Risk for Cardiovascular Disease Higher in Survivors of Testicular Cancer

Results from the ongoing Platinum Study revealed the prevalence of risk factors for CVD among survivors of testicular cancer who received chemotherapy for their cancer.

Risk Factors for Cardiovascular Disease in Youth With Type 1 Diabetes

Risk Factors for Cardiovascular Disease in Youth With Type 1 Diabetes

Early treatment of cardiovascular disease risk factors such as dyslipidemia and hypertension will have long-term benefits with low risk and cost and should be more widely used in pediatric type 1 diabetes care.

Only Half of Adults With Familial Hypercholesterolemia on Statins

Only Half of Adults With Familial Hypercholesterolemia on Statins

Only about 50% of adults with familial hypercholesterolemia are on statin therapy, and approximately 30% of those are taking high-intensity statins.

Change in BMI During Puberty Tied to Later Heart Failure Risk in Men

Change in BMI During Puberty Tied to Later Heart Failure Risk in Men

Change in body mass index to overweight during puberty significantly increases men's risk of heart failure later in life.

Negative Symptoms Increase Cardiovascular Risk in Schizophrenia

Negative Symptoms Increase Cardiovascular Risk in Schizophrenia

Although various clinical and psychosocial factors were associated with unhealthy lifestyle factors and higher risk for CVD, the strongest associations were with negative symptoms.

Effect of Menopausal Hormone Therapy on Cardiac Structure, Function

Effect of Menopausal Hormone Therapy on Cardiac Structure, Function

Researchers examined the effect of menopausal hormone therapy on left ventricular and left atrial chamber structure and function changes, which are markers of subclinical cardiovascular disease.

Metformin Use Linked to Reduced Risk of Statin-Associated Muscle Pain

Metformin Use Linked to Reduced Risk of Statin-Associated Muscle Pain

Statin-associated muscle pain can hinder medication adherence which could potentially lead to an increased risk of cardiovascular events.

Influence of Gender on Cardiovascular Risk and Glycemic Control in T1D

Influence of Gender on Cardiovascular Risk and Glycemic Control in T1D

Researchers assessed differences in glycemic control, major cardiovascular risk factors, diabetes-related complications, sexual dysfunction prevalence, and endothelial function in young men and women with type 1 diabetes.

No Cardiovascular Benefit With Fenofibrate in T2D and Hypertriglyceridemia

No Cardiovascular Benefit With Fenofibrate in T2D and Hypertriglyceridemia

Statins were associated with a reduction in mortality but there was no significant difference in the composite end point with fenofibrates alone or in combination with statins.

Obesity May Increase Cardiovascular Morbidity, Mortality

Obesity May Increase Cardiovascular Morbidity, Mortality

Results provide critical perspective on cardiovascular disease associated with overweight and obesity and challenge both the obesity paradox as well as the view that overweight is associated with greater longevity.

Proliferative Diabetic Retinopathy Independently Associated With CVD in T1D

Proliferative Diabetic Retinopathy Independently Associated With CVD in T1D

Study found that the absence of proliferative diabetic retinopathy in those with stage 3b chronic kidney disease is associated with a lower prevalence of cardiovascular disease in patients with long duration of type 1 diabetes.

Prevalence, Effect of Undetected Diabetes in Percutaneous Coronary Intervention

Prevalence, Effect of Undetected Diabetes in Percutaneous Coronary Intervention

Abnormal glucose metabolism was detected in 1 out of 3 patients with nondiabetic percutaneous coronary intervention and was independently associated with a significantly higher event risk.

Sulfonylureas and Risk of Sudden Cardiac Arrest, Ventricular Arrhythmia Examined

Sulfonylureas and Risk of Sudden Cardiac Arrest, Ventricular Arrhythmia Examined

Study examined the association between individual antidiabetic sulfonylureas and outpatient-originating sudden cardiac arrest and ventricular arrhythmia.

Increased Adiposity Raises Myocardial Infarction Risk More in Women

Increased Adiposity Raises Myocardial Infarction Risk More in Women

Increases in waist circumference and waist-to-hip ratio are associated with a greater excess risk of myocardial infarction in women than men.

Effect of Fenofibrate Varies Widely in Type 2 Diabetes

Effect of Fenofibrate Varies Widely in Type 2 Diabetes

The method of individualized treatment effect prediction of fenofibrate on major cardiovascular events risk reduction in T2D can be used to guide clinical decision-making.

Predicting Mortality Following Acute Myocardial Infarction in Diabetes

Predicting Mortality Following Acute Myocardial Infarction in Diabetes

The acute-to-chronic glycemic ratio provided better prognostic insight with regard to in-hospital mortality and morbidity outcomes compared with glycemia levels at hospital admission in patients with diabetes who had an acute myocardial infarction.

Prior Authorization Requirements Greater for PCSK9 Inhibitors

Prior Authorization Requirements Greater for PCSK9 Inhibitors

Prior authorization requirements are greater for proprotein convertase subtilisin/kexin type 9 inhibitors than for other cardiometabolic drugs.

Lipid Metabolism Imbalance and Pathophysiology of Bipolar Disease

Lipid Metabolism Imbalance and Pathophysiology of Bipolar Disease

Abnormal ratios of omega-6 to omega-3 fatty acids were associated with the presence of bipolar disorder and the severity and duration of major depressive disorder.

Case: A 67-Year-Old Man With Shortness of Breath After Wildfires

Case: A 67-Year-Old Man With Shortness of Breath After Wildfires

A patient living near an area experiencing frequent wildfires is concerned about the potential negative effect that the wildfires may have on his health.

Sudden Sensorineural Hearing Loss Recovery Lower With Metabolic Syndrome

Sudden Sensorineural Hearing Loss Recovery Lower With Metabolic Syndrome

Patients with metabolic syndrome have a lower rate of recovery from sudden sensorineural hearing loss than those without.

T2D May Play a Protective Role Against Developing Aortic Diseases

T2D May Play a Protective Role Against Developing Aortic Diseases

The novel findings in this study suggest that patients with type 2 diabetes have a significantly reduced risk for short-term mortality after hospitalization for aortic aneurysm compared with population-based control subjects.

Reducing CV Risk in Patients With Rheumatoid Arthritis and Diabetes

Reducing CV Risk in Patients With Rheumatoid Arthritis and Diabetes

Abatacept conferred a greater reduction in cardiovascular risk compared with tumor necrosis factor inhibitors in patients with rheumatoid arthritis and diabetes.

Little Effect on Metabolic Risk Factors With Addition of SSRIs to Antipsychotics

Little Effect on Metabolic Risk Factors With Addition of SSRIs to Antipsychotics

A combination of selective serotonin reuptake inhibitors and antipsychotics does not lead to further deterioration of metabolic variables; however, metabolic monitoring should be performed.

Updated Standards of Medical Care in Diabetes Focuses on Cardiovascular Disease

Updated Standards of Medical Care in Diabetes Focuses on Cardiovascular Disease

ADA's recommendations reflect the latest advances in evidence-based research to improve care for millions of people with diabetes.

Duration of Prediabetes, Diabetes Independently Associated With Subclinical Atherosclerosis, Cardiac Dysfunction

Duration of Prediabetes, Diabetes Independently Associated With Subclinical Atherosclerosis, Cardiac Dysfunction

Data emphasize the importance of early identification and management of those at risk for diabetes and prediabetes in order to limit exposure to the adverse cardiovascular effects of a longer duration of these conditions.

Lower Bone Mineral Density May Increase Intracranial Aneurysm Risk

Lower Bone Mineral Density May Increase Intracranial Aneurysm Risk

A lower bone mineral density in the lumbar spine, femoral neck, and hip is associated with an increased risk for intracranial aneurysm.

Gestational Diabetes May Increase Risk for Hypertension, Ischemic Heart Disease, T2D

Gestational Diabetes May Increase Risk for Hypertension, Ischemic Heart Disease, T2D

Clinical guidelines should include postpartum screening and management for all cardiovascular risk factors in women diagnosed with gestational diabetes and not restrict it to diabetes.

Does Bariatric Surgery Reduce CVD Risk Factors in Adolescents?

Does Bariatric Surgery Reduce CVD Risk Factors in Adolescents?

Weight loss after bariatric surgery in adolescents predicts the degree of longitudinal improvement in elevated high-sensitivity C-reactive protein, hyperinsulinemia, dyslipidemia, and diabetes.

New Recommendations for High Blood Pressure Management, Prevention

New Recommendations for High Blood Pressure Management, Prevention

New recommendations have been developed for the prevention, detection, evaluation, and management of high blood pressure.

Adding Ezetimibe to Statin Therapy: Cardiovascular Outcomes in Diabetes

Adding Ezetimibe to Statin Therapy: Cardiovascular Outcomes in Diabetes

In patients with an acute coronary syndrome and LDL-C >50 mg/dL, healthcare providers should consider adding ezetimibe to statin therapy to reduce the risk of cardiovascular events.

Repeat Blood Pressure Readings in Children Prevents Unnecessary Follow-up

Repeat Blood Pressure Readings in Children Prevents Unnecessary Follow-up

Only approximately half of pediatric patients with a blood pressure reading ≥95th percentile would be correctly classified based on their initial blood pressure reading.

Plasma Volume Changes Mediate Risk of CV Mortality With Empagliflozin

Plasma Volume Changes Mediate Risk of CV Mortality With Empagliflozin

The reduction in risk of cardiovascular death with empagliflozin is most mediated by changes in hematocrit and hemoglobin.

Higher Risk for Stroke, MI in Patients With Gout, Diabetes

Higher Risk for Stroke, MI in Patients With Gout, Diabetes

Patients with both gout and diabetes are at a much higher risk for stroke and myocardial infarction than with diabetes alone.

Intensive Blood Pressure Lowering Reduces CV Events Similarly in Patients With/Without T2D

Intensive Blood Pressure Lowering Reduces CV Events Similarly in Patients With/Without T2D

Researchers assessed the effect of both type 2 diabetes and baseline cardiovascular disease risk on the treatment effect of intensive blood pressure lowering based on data and pooled analysis from 14,094 patients.

Subclinical Primary Aldosteronism Increases Hypertension Risk in Normotensive Patients

Subclinical Primary Aldosteronism Increases Hypertension Risk in Normotensive Patients

Future studies using a renin phenotype-driven approach may efficiently identify new-onset or mild hypertension.

CV Event Prediction, Risk Assessment in Type 2 Diabetes

CV Event Prediction, Risk Assessment in Type 2 Diabetes

Risk of cardiovascular events in people with type 2 diabetes and subgroups of coronary artery disease was examined.

Vascular Endothelial Dysfunction Involved in Hypertension Development in T1D

Vascular Endothelial Dysfunction Involved in Hypertension Development in T1D

A life-course study evaluated the contribution of vascular endothelial dysfunction and inflammation to the development of hypertension in type 1 diabetes.

Urinary Albumin-to-Creatinine Ratio Aids CV Risk Assessment in T2D

Urinary Albumin-to-Creatinine Ratio Aids CV Risk Assessment in T2D

Urinary albumin-to-creatinine ratio can be independently associated with various adverse CV outcomes.

Coronary Artery Bypass Grafting: Preferred Method of Revascularization in Diabetes

Coronary Artery Bypass Grafting: Preferred Method of Revascularization in Diabetes

In patients with diabetes, coronary artery bypass grafting may be the preferred method of revascularization, with lower rates of major adverse cardiac or cerebrovascular events.

Physical Activity, Sedentary Time May Increase Cardiometabolic Risk Markers in Prediabetes

Physical Activity, Sedentary Time May Increase Cardiometabolic Risk Markers in Prediabetes

A study sought to clarify whether total physical activity during the day is equally as important as achieving high levels of intensity associated with moderate-to-vigorous physical activity.

More Evidence That Saxagliptin Does Not Increase Risk for AMI in Diabetes

More Evidence That Saxagliptin Does Not Increase Risk for AMI in Diabetes

Patients with diabetes taking saxagliptin, sitagliptin, second-generation sulfonylureas, pioglitazone, and long-acting insulin were assessed for the risk of acute myocardial infarction.

Elderly Patients With T2D, Heart Failure Have High Risk for Mortality

Elderly Patients With T2D, Heart Failure Have High Risk for Mortality

A strong association was found in study between poor survival in elderly patients with type 2 diabetes and cardiovascular complications, especially heart failure.

Hypertensive Disorders During Pregnancy Increase Risk for Future CVD

Hypertensive Disorders During Pregnancy Increase Risk for Future CVD

Women with hypertensive disorders during pregnancy have a significantly greater risk for future cardiovascular disease when compared with normotensive expecting mothers.

Case Study: Man With Obesity, Hypertension Presenting With Worsening Palpitations

Case Study: Man With Obesity, Hypertension Presenting With Worsening Palpitations

A man presents to the emergency department having had palpitations for the past week, and he has a medical history of hypertension, obesity, and hyperlipidemia. What's the diagnosis?

CVD Hospitalization Rates in Diabetes Decreased in 1998-2014

CVD Hospitalization Rates in Diabetes Decreased in 1998-2014

Cardiovascular disease hospitalization rates have declined in recent years among individuals with and those without diabetes.

Higher Childhood BMI Associated With Adult Ischemic Stroke

Higher Childhood BMI Associated With Adult Ischemic Stroke

Higher childhood body mass index and increases in BMI during childhood are linked to an increased risk of early adult ischemic stroke.

Insulin-Induced Weight Gain Not Associated With Adverse CV Outcomes in T2D

Insulin-Induced Weight Gain Not Associated With Adverse CV Outcomes in T2D

Despite the well‐recognized correlation between weight gain and cardiovascular (CV) disease, there is little direct evidence relating to the impact of insulin‐induced weight gain on CV outcomes.

Stopping Postmenopausal HT May Increase Risk for Cardiac, Stroke Death

Stopping Postmenopausal HT May Increase Risk for Cardiac, Stroke Death

Increased mortality risks were limited to the first post-HT year because increases in risks markedly decreased when the follow-up time was extended over more than 1 year.

No Difference in Cardiovascular Outcomes With Exenatide vs Placebo in T2D

No Difference in Cardiovascular Outcomes With Exenatide vs Placebo in T2D

Once-weekly administration of extended-release exenatide in patients with T2D at a wide range of cardiovascular risk appeared not to cause an increase in their overall cardiovascular risk.

Empagliflozin Reduces CVD Risk in Patients With T2D and PAD

Empagliflozin Reduces CVD Risk in Patients With T2D and PAD

Empagliflozin lowered the risk of cardiovascular death vs placebo when added to standard of care in adults with both type 2 diabetes and peripheral artery disease.

High-Sensitivity CRP and LDL-C Predictive of Subsequent MACE in T2D

High-Sensitivity CRP and LDL-C Predictive of Subsequent MACE in T2D

Levels of high sensitivity C-reactive protein may help risk stratify those patients with T2D and recent acute coronary syndrome at further risk of recurrent cardiovascular events.

High Grip Strength Associated With Lower Risk for Diabetes-Related AEs

High Grip Strength Associated With Lower Risk for Diabetes-Related AEs

Grip strength has clinical utility in identifying people with diabetes at risk for poor health outcomes.

Statin Use for CVD Prevention Increases Diabetes Risk in Overweight Patients

Statin Use for CVD Prevention Increases Diabetes Risk in Overweight Patients

The association between statin use and diabetes risk in a cohort of overweight and obese patients was examined.

FDA Approves Drug for Mucopolysaccharidosis Type VII

FDA Approves Drug for Mucopolysaccharidosis Type VII

Mepsevii replaces beta-glucuronidase, the deficiency of which causes an abnormal buildup of toxic materials in the body's cells.

Postpartum Hypertension in Preeclampsia: Do Puerperal NSAIDs Effect Risk?

Postpartum Hypertension in Preeclampsia: Do Puerperal NSAIDs Effect Risk?

Investigators encourage further research on the use of NSAIDs in women with preeclampsia who develop postpartum hypertension.

Improving Vascular Function in Pediatric T1D With Metformin

Improving Vascular Function in Pediatric T1D With Metformin

Study aimed to determine the effect of metformin on vascular health in children with T1D and above average weight.

Acarbose Reduces Diabetes Risk in Coronary Heart Disease

Acarbose Reduces Diabetes Risk in Coronary Heart Disease

Acarbose, an α-glucosidase inhibitor, decreased the incidence of diabetes in a population with impaired glucose tolerance who were at low risk of cardiovascular events.

Improving NSTEMI Outcomes in T2D With NOCS: Efficacy of Incretin

Improving NSTEMI Outcomes in T2D With NOCS: Efficacy of Incretin

People with type 2 diabetes and NOCS-NSTEMI who used incretin had a better prognosis than non-incretin users.

Severe Hypoglycemia Associated With Increased Mortality Risk in T2D

Severe Hypoglycemia Associated With Increased Mortality Risk in T2D

A study confirms whether severe hypoglycemia increases risk for all-cause mortality in patients with type 2 diabetes.

Glucose Patterns and the Future Development of Diabetes

Glucose Patterns and the Future Development of Diabetes

Study revealed heterogeneity in plasma glucose response to oral glucose intake beyond the established glucose criteria based on fasting plasma glucose and 2 h post-load plasma glucose levels.

Gestational Diabetes Associated With Adiposity, Puberty Onset in Offspring

Gestational Diabetes Associated With Adiposity, Puberty Onset in Offspring

Researchers assessed the impact of maternal gestational diabetes on insulin resistance and adiposity in adolescent offspring.

Type 2 Diabetes Protective Against Aortic Aneurysm, Dissection

Type 2 Diabetes Protective Against Aortic Aneurysm, Dissection

Studies have not previously examined long-term risks or mortality after aortic aneurysm or dissection in people with type 2 diabetes.

Ventricular Function With Vildagliptin in T2D and CHF

Ventricular Function With Vildagliptin in T2D and CHF

Study highlights the need to examine the safety of new glucose-lowering treatments specifically in patients with diabetes and heart failure and reduced ejection fraction.

HbA1c Predictive of Poor Heart Failure Outcomes in T2D

HbA1c Predictive of Poor Heart Failure Outcomes in T2D

Based on glycemic control and treatment method, type 2 diabetes in the heart failure population can be indicative of various risk associations.

Sudden Death in T2D: Examining the Most Common Cause of CV Mortality

Sudden Death in T2D: Examining the Most Common Cause of CV Mortality

Heart failure prevention may be an opportunity to reduce the risk of death in specific cardiovascular subcategories.

High-Dose Beta-Blockers More Effective in Chronic Heart Failure, Diabetes

High-Dose Beta-Blockers More Effective in Chronic Heart Failure, Diabetes

Greater prognostic advantages were associated with high-dose beta blockers in chronic heart failure with diabetes.

ADA Position Statement Update: Hypertension Management in Diabetes

ADA Position Statement Update: Hypertension Management in Diabetes

The latest ADA hypertension position statement incorporates advances in care since 2003.

Evolocumab May Decrease Cardiovascular Risk in Patients With and Without Diabetes

Evolocumab May Decrease Cardiovascular Risk in Patients With and Without Diabetes

PCSK9 inhibition with evolocumab might be an attractive therapy in patients with diabetes, and no discernible effect on glycaemia.

SPRINT Update: Positive CVD Outcomes With Intensive Blood Pressure Management in Prediabetes

SPRINT Update: Positive CVD Outcomes With Intensive Blood Pressure Management in Prediabetes

Patients with prediabetes who experienced intensive blood pressure management had better outcomes with CVD events and all-cause mortality.

Examining Inclusion of T2D Medication Adherence Data in Studies

Examining Inclusion of T2D Medication Adherence Data in Studies

Results suggest that medication adherence is associated with reduced risk of all-cause mortality in T2D.

Predicting Adult MetS, T2D, CV Risks in Childhood

Predicting Adult MetS, T2D, CV Risks in Childhood

BMI measurement alone can also be used to determine associations between childhood and adulthood conditions.

ICU Resource Use After Cardiac Surgery Increased With Obesity

ICU Resource Use After Cardiac Surgery Increased With Obesity

Increasing obesity is associated with increased ICU resource utilization in patients undergoing cardiac surgery.

Statins Beneficial for High-Risk Patients Despite Adverse Reactions

Statins Beneficial for High-Risk Patients Despite Adverse Reactions

From 25% to 50% of patients discontinue statins within 6 months to 1 year of starting, and the rate increases as high as 75% after 2 years.

Stroke Risk Upped With High Childhood BMI

Stroke Risk Upped With High Childhood BMI

Increases in BMI z-score between 7 and 13 years of age increase a person's risk of ischemic stroke in early adulthood.

Following Ischemic Stroke, Glycemic Control Indicative of Short-Term Outcomes

Following Ischemic Stroke, Glycemic Control Indicative of Short-Term Outcomes

Hyperglycemia treatment was left to physician's discretion.

AAP: Updated Guidelines for Managing High Blood Pressure in Children

AAP: Updated Guidelines for Managing High Blood Pressure in Children

The American Academy of Pediatrics released an update to previous hypertension management updates published in 2004.

Predicting Coronary Artery Events in T2D With Imaging Plus Risk Factor Assessment

Predicting Coronary Artery Events in T2D With Imaging Plus Risk Factor Assessment

Patients with MACE showed a greater extent of more severe coronary artery disease.

Strategies for Multivessel Revascularization in T1D: CABG vs PCI

Strategies for Multivessel Revascularization in T1D: CABG vs PCI

PCI has been linked to increased risk of CHD, mortality, MI, and repeat revascularization in type 1 diabetes.

Cardiovascular, Renal Outcomes in Type 1 Diabetes

Cardiovascular, Renal Outcomes in Type 1 Diabetes

More awareness for afib risk factors including age, severity of complications, and glycemic status are needed.

Lowering Heart Failure Hospitalizations in T2D: SGLT2 vs DPP4 Inhibitors

Lowering Heart Failure Hospitalizations in T2D: SGLT2 vs DPP4 Inhibitors

A retrospective analysis examined outcomes in patients with type 2 diabetes treated with SGLT2 vs DPP4 inhibitors.

Population at Risk: CVD Events Increased in Metabolically Healthy Obese

Population at Risk: CVD Events Increased in Metabolically Healthy Obese

Researchers created body size phenotypes, defined by BMI category, to assess CVD incidence in a metabolically healthy obese population.

Atrial Fibrillation With Diabetes: Risk for Cardiovascular Events in Women vs Men

Atrial Fibrillation With Diabetes: Risk for Cardiovascular Events in Women vs Men

Women with atrial fibrillation and diabetes had a higher risk for mortality and cardiovascular complications compared with men.

Examined: Correlation Between Weight Increase and Heart Failure Risk

Examined: Correlation Between Weight Increase and Heart Failure Risk

Losing weight may result in a decrease of heart muscle thickness.

Cardiovascular Event Risks With Zoledronic Acid vs Oral Bisphosphonates

Cardiovascular Event Risks With Zoledronic Acid vs Oral Bisphosphonates

Patients treated with zoledronic acid vs oral bisphosphonates had higher risk for heart failure and arrhythmias.

Comparing Early, Delayed Invasive Strategy in Non-ST-Elevation Acute Coronary Syndromes

Comparing Early, Delayed Invasive Strategy in Non-ST-Elevation Acute Coronary Syndromes

An early invasive strategy in patients with non-ST-elevation acute coronary syndromes does not necessarily reduce mortality compared with a delayed strategy.

Sign Up for Free e-Newsletters



CME Focus